Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

USTEKINUMAB-TTWE for Colitis ulcerative: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where USTEKINUMAB-TTWE was used for Colitis ulcerative.

Most Reported Side Effects for USTEKINUMAB-TTWE

Side Effect Reports % Deaths Hosp.
Crohn's disease 8 9.6% 0 1
Off label use 8 9.6% 0 3
Fatigue 7 8.4% 0 0
Drug ineffective 6 7.2% 0 2
Lower respiratory tract infection 6 7.2% 0 2
Dyspnoea 5 6.0% 0 2
Headache 5 6.0% 0 0
Infection 5 6.0% 0 4
Pruritus 5 6.0% 0 1

Other Indications for USTEKINUMAB-TTWE

Crohn's disease (52) Psoriasis (15) Product used for unknown indication (8)

Other Drugs Used for Colitis ulcerative

ADALIMUMAB (34,530) VEDOLIZUMAB (33,987) INFLIXIMAB (21,373) INFLIXIMAB-DYYB (6,767) TOFACITINIB (6,358) MESALAMINE (6,347) UPADACITINIB (4,800) USTEKINUMAB (3,872) GOLIMUMAB (3,637) HUMIRA (2,707)

Related Pages

USTEKINUMAB-TTWE Full Profile All Colitis ulcerative Drugs USTEKINUMAB-TTWE Demographics USTEKINUMAB-TTWE Timeline